Impact of severe hypoglycemia on the heat shock and related protein response.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 08 2021
Historique:
received: 27 04 2021
accepted: 13 08 2021
entrez: 24 8 2021
pubmed: 25 8 2021
medline: 3 11 2021
Statut: epublish

Résumé

Heat shock proteins contribute to diabetes-induced complications and are affected by glycemic control. Our hypothesis was that hypoglycemia-induced heat shock and related protein changes would be amplified in type 2 diabetes (T2D). This prospective, case-control study enrolled 23 T2D patients and 23 control subjects who underwent hyperinsulinemic-induced hypoglycemia (≤ 2.0 mmol/L (36 mg/dl)) with blood sampling at baseline, at hypoglycemia and after a 24-h post-hypoglycemia follow-up period. Proteomic analysis of heat shock-related and pro-inflammatory proteins was performed. At baseline, MAPKAPK5 (p = 0.02) and UBE2G2 (p = 0.003) were elevated and STUB1 decreased (p = 0.007) in T2D. At hypoglycemia: PPP3CA (p < 0.03) was increased and EPHA2 (p = 0.01) reduced in T2D; by contrast, three proteins were reduced in controls [HSPA1A (p = 0.007), HSPB1 (p < 0.02), SMAD3 (p = 0.005)] while only MAPKAPK5 was elevated (p = 0.02). In the post-hypoglycemia follow-up period, most proteins normalized to baseline by 24-h; however, STIP1 (p = 0.003), UBE2N (p = 0.004) and UBE2L3 (p < 0.04) were decreased in controls at 24-h. No protein differed from baseline at 24-h in T2D. Pro-inflammatory interleukin-6 increased at 4-h post-hypoglycemia in controls and T2D (p < 0.05 and p < 0.003, respectively) and correlated with HSPA1A; anti-inflammatory IL-10 decreased 2-h post-hypoglycemia in T2D only. Other pro-inflammatory proteins, IL-1α, IFN-γ and TNF-α, were unchanged. Heat shock and related proteins differed at baseline between T2D and controls, with an exaggerated response of heat shock and related proteins to hypoglycemia that returned to baseline, though with changes at 24-h in controls alone. An increase in pro-inflammatory IL-6, with a decrease in anti-inflammatory IL-10, suggests that the HSP system is overactivated due to underlying inflammation in T2D.Trial registration: ClinicalTrials.gov NCT03102801.

Identifiants

pubmed: 34426634
doi: 10.1038/s41598-021-96642-8
pii: 10.1038/s41598-021-96642-8
pmc: PMC8382834
doi:

Substances chimiques

EPHA2 protein, human 0
HSP70 Heat-Shock Proteins 0
HSPA1A protein, human 0
HSPB1 protein, human 0
Heat-Shock Proteins 0
Interleukins 0
Intracellular Signaling Peptides and Proteins 0
Molecular Chaperones 0
Proteome 0
SMAD3 protein, human 0
Smad3 Protein 0
Tumor Necrosis Factor-alpha 0
MAP-kinase-activated kinase 5 6YHG2VE3IX
Interferon-gamma 82115-62-6
UBE2G2 protein, human EC 2.3.2.23
Ubiquitin-Conjugating Enzymes EC 2.3.2.23
STUB1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Receptor, EphA2 EC 2.7.10.1
Protein Serine-Threonine Kinases EC 2.7.11.1

Banques de données

ClinicalTrials.gov
['NCT03102801']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17057

Informations de copyright

© 2021. The Author(s).

Références

FASEB J. 2017 May;31(5):2157-2167
pubmed: 28196897
Diabetes Obes Metab. 2021 Feb;23(2):338-349
pubmed: 33026133
Diabetes Res Clin Pract. 2016 Dec;122:54-61
pubmed: 27810686
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Cell Stress Chaperones. 2018 Sep;23(5):955-965
pubmed: 29752628
Biochem Biophys Res Commun. 1986 Nov 26;141(1):46-52
pubmed: 3801007
Nat Commun. 2017 Feb 27;8:14357
pubmed: 28240269
J Biol Chem. 2009 May 1;284(18):12246-57
pubmed: 19265200
Diabetes Obes Metab. 2019 Mar;21(3):533-540
pubmed: 30264480
J Diabetes Complications. 2016 Sep-Oct;30(7):1275-81
pubmed: 27445005
Mol Neurobiol. 2004 Oct;30(2):201-21
pubmed: 15475627
BMJ Open Diabetes Res Care. 2021 Apr;9(1):
pubmed: 33879515
EMBO J. 2017 Apr 13;36(8):1046-1065
pubmed: 28283579
J Intern Med. 2009 Dec;266(6):527-36
pubmed: 19563392
J Diabetes Complications. 2018 Feb;32(2):221-225
pubmed: 29175119
Lab Invest. 2012 Jan;92(1):32-45
pubmed: 21931298
Int J Mol Sci. 2017 Dec 14;18(12):
pubmed: 29240668
Diabetes. 2008 Jul;57(7):1966-70
pubmed: 18390793
Can J Diabetes. 2016 Dec;40(6):594-602
pubmed: 27545596
Sci Rep. 2020 Mar 16;10(1):4750
pubmed: 32179763
Nature. 2012 May 06;485(7399):507-11
pubmed: 22622579
J Gastrointest Surg. 2010 Mar;14(3):528-35
pubmed: 19997981
Int J Biochem Cell Biol. 2014 Feb;47:29-37
pubmed: 24309468
Physiol Rev. 2008 Oct;88(4):1379-406
pubmed: 18923185
Cell Stress Chaperones. 2009 Jan;14(1):105-11
pubmed: 18663603
Int J Biol Sci. 2019 Jan 1;15(2):312-324
pubmed: 30745823
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Neurosci Res. 2019 Oct;147:26-32
pubmed: 30444976
PLoS One. 2010 Dec 07;5(12):e15004
pubmed: 21165148
Cell Stress Chaperones. 2009 Mar;14(2):113-5
pubmed: 18720028
Cell Stress Chaperones. 2019 Jan;24(1):7-15
pubmed: 30478692
Cell Death Dis. 2013 Jun 13;4:e666
pubmed: 23764847
PLoS One. 2011;6(10):e26332
pubmed: 22022604
J Neuroinflammation. 2017 Apr 24;14(1):90
pubmed: 28438174
Diabetes. 2009 Apr;58(4):773-95
pubmed: 19336687
J Exp Biol. 2003 Apr;206(Pt 7):1107-15
pubmed: 12604570
Diabetes. 2002 Apr;51(4):1102-9
pubmed: 11916932
Diabetes. 2005 Dec;54 Suppl 2:S114-24
pubmed: 16306329
Trends Mol Med. 2015 Jul;21(7):439-49
pubmed: 25998900
Brain Res Mol Brain Res. 2005 Sep 13;139(1):80-7
pubmed: 15961182
Int J Mol Sci. 2020 Nov 02;21(21):
pubmed: 33147803
Acta Diabetol. 2013 Aug;50(4):579-85
pubmed: 22068623
Cell Stress Chaperones. 2003 Winter;8(4):303-8
pubmed: 15115282
Stat Med. 1994 Dec 15-30;13(23-24):2455-63
pubmed: 7701146
J Biol Chem. 2008 Jun 6;283(23):16017-26
pubmed: 18387945
PeerJ. 2020 Feb 20;8:e8638
pubmed: 32117642
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738):
pubmed: 29203707
Diabetes. 2011 Jan;60(1):227-38
pubmed: 20980462
Anesthesiology. 2008 Mar;108(3):402-14
pubmed: 18292678
Hum Mol Genet. 2018 Apr 15;27(8):1421-1433
pubmed: 29432562
Ann Intern Med. 2007 Aug 7;147(3):149-55
pubmed: 17576993

Auteurs

Alexander S Atkin (AS)

Trinity College, Cambridge University, Cambridge, UK.

Abu Saleh Md Moin (ASM)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.

Manjula Nandakumar (M)

Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.

Ahmed Al-Qaissi (A)

Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK.
Leeds Medical School, Leeds, UK.

Thozhukat Sathyapalan (T)

Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK.

Stephen L Atkin (SL)

Royal College of Surgeons of Ireland, PO Box 15503, Adliya, Bahrain.

Alexandra E Butler (AE)

Royal College of Surgeons of Ireland, PO Box 15503, Adliya, Bahrain. abutler@rcsi.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH